Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma

Urology

Volumn 67, Issue 1, 2006, Pages 105-109

  Krüger, Stefan ^a   Mahnken, Anne ^a   Kausch, Ingo ^a   Feller, Alfred C ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STAINING; TISSUE MICROARRAY; TUMOR CELL; UROGENITAL TRACT TUMOR;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CLUSTERIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 30344434661     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.04.043     Document Type: Article

References (29)

1. D.E. Jenne, J. Tschopp Clusterin the intriguing guises of a widely expressed glycoprotein Trends Biochem Sci 17 1992 154 159
2. T.C. Jordan-Stark, D.P. Witte, B. Aronow Apolipoprotein J a membrane policeman? Curr Opin Lipidol 3 1992 75 85
3. I.B. Fritz, C. Burdzy, B. Stechell Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro Biol Reprod 28 1993 1173 1188
4. P.C. May Sulfated glycoprotein-2 an emerging molecular marker for neurodegeneration Ann NY Acad Sci 679 1993 235 244
5. D.P. Witte, B.J. Aronow, J.K. Dry Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis Dev Dyn 201 1994 290 296
6. E.L. Calvo, G.V. Mallo, F. Fiedler Clusterin overexpression in rat pancreas during the acute phase of pancreatitis and pancreatic development Eur J Biochem 254 1998 282 289
7. R. Correa-Rotter, M.E. Ibarra-Rubio, G. Schwochau Induction of clusterin in tubules of nephrotic rats J Am Soc Nephrol 9 1998 33 37
8. W. Wunsche, M.P. Tenniswood, M.R. Schneider Estrogenic regulation of clusterin mRNA in normal and malignant endometrial tissue Int J Cancer 76 1998 684 688
9. J. O'Sullivan, L. Whyte, J. Drake Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis Cell Death Differ 10 2003 914 927
10. J.A. Sensibar, D.M. Sutkowski, A. Raffo Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulphated glycoprotein-2 (clusterin) Cancer Res 55 1995 2431 2437
11. A.J. Wu, I.I. Park, L. Zhaung Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoptosis in prostate and bladder cancer cells Prostate 53 2002 277 285
12. H. Miyake, I. Hara, S. Kamidono Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model Clin Cancer Res 7 2001 4245 4252
13. H. Miyake, M. Gleave, S. Kamidono Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence Urology 50 2002 150 154
14. J.I. Epstein, M.B. Amin, V.R. Reuter The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder Am J Surg Pathol 22 1998 1435 1448
15. A. Nocito, L. Bubendorf, E. Maria-Tinner Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade J Pathol 194 2001 349 357
16. C. Thorns, F. Noack, A.C. Feller Application of newly developed tissue-arrays to study EMMPRIN (CD147) expression in malignant non-Hodgkin lymphoma Cancer Genomics Proteomics 1 2004 45 50
17. M. Redondo, E. Villar, J. Torres-Munoz Overexpression of clusterin in human breast carcinoma Am J Pathol 157 2000 393 399
18. J.P. Stein, G. Lieskovsky, R. Cote Radical cystectomy in the treatment of invasive bladder cancer long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
19. J.P. Stein, G.D. Grossfeld, D.A. Ginsberg Prognostic markers in bladder cancer a contemporary review of the literature J Urol 160 1998 645 659
20. D. Esrig, D. Elmajian, S. Groshen Accumulation of nuclear p53 and tumor progression in bladder cancer N Engl J Med 331 1994 1259 1264
21. A. Haitel, B. Posch, M. El-Baz Bilharzial related, organ confined, muscle-invasive bladder cancer prognostic value of apoptosis markers, proliferation markers, p53, e-cadherin, epidermal growth factor receptor and c-erbB-2 J Urol 165 2001 1481 1487
22. S. Kruger, G. Weitsch, H. Buttner Her2 overexpression in muscle-invasive urothelial carcinoma of the bladder prognostic implications Int J Cancer 102 2002 514 518
23. R. Tiguert, A. Lessard, A. So Prognostic markers in muscle invasive bladder cancer World J Urol 20 2002 190 195
24. S.F. Shariat, H. Tokunaga, J. Zhou p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer J Clin Oncol 22 2004 1014 1024
25. J. Steinberg, R. Oyasu, S. Lang Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer Clin Cancer Res 3 1997 1707 1711
26. T. Criswell, D. Klokov, M. Beman Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein Cancer Biol Ther 2 2003 372 380
27. T. Chen, J. Turner, S. McCarthy Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent Cancer Res 64 2004 7412 7419
28. H. Miyake, S. Hara, T. Zellweger Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells Mol Urol 5 2004 105 111
29. N. Kyprianou, S. Rock Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression Anticancer Res 18 1998 897 905